FHFT-C-Managed Service Contract for Provision of Blood Cultures Testing Services

The procurement process managed by Frimley Health NHS Foundation Trust has concluded with the award of a managed service contract for pathology services, specifically the provision of blood culture testing services. The contract, valued at £1,230,052, was awarded to Chrystal Medical Limited, a supplier based in Manchester. This project falls under the healthcare industry category and was conducted as a framework direct award via the East of England Framework, aiming to maintain current service provision while the Trust prepares for a re-tender.

The procurement process was completed without a prior public call for competition, adhering to the procurement method rationale that this situation falls outside the standard scope, as of 13th June 2025. The services associated with this contract are to be delivered across multiple regions in the UK, including UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, and UKK. This tender represents a key opportunity for growth for businesses specialising in pathology services, medical testing, or healthcare solutions, particularly those capable of providing managed services in a rapidly evolving healthcare environment.

SMEs such as Chrystal Medical Limited, which was awarded the contract, are particularly well-suited to enter this market due to their ability to offer specialised, adaptable solutions. The ongoing demand for continuity and excellence in healthcare service provision in multiple UK regions offers a promising avenue for companies with strong expertise in medical diagnostics and services to compete and expand their market presence.